Teva Posts $590m Negative EBITDA Amid Opioid Deal And Write-Offs
Russian Invasion Of Ukraine Causes Massive Goodwill Impairment
Teva’s EBITDA was in the red to the tune of more than half a billion dollars in Q2, after taking a chunk out of the company’s goodwill and adding more than $700m to its loss contingency for opioid-related claims.
